Search

Author/Creator Kaur, Manmit

1. Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer. Issue 1 (2nd January 2023)

Authors:
Yang, James Chih-Hsin; Zhou, Caicun; Jänne, Pasi A.; Ramalingam, Suresh S.; Kim, Tae Min; Riely, Gregory J; Spira, Alexander I; Piotrowska, Zofia; Mekhail, Tarek; Garcia Campelo, Maria Rosario; Felip, Enriqueta; Bazhenova, Lyudmila; Jin, Shu; Kaur, Manmit; Diderichsen, Paul M.; Gupta, Neeraj; Bun...
Journal:
Expert review of anticancer therapy
Issue:
Volume 23:Issue 1(2023)
Page Start:
95
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study. (April 2023)

Authors:
Popat, Sanjay; Ramalingam, Suresh; Zhou, Caicun; Kim, Tae; Yang, James; Riely, Gregory; Mekhail, Tarek; Nguyen, Danny; Garcia Campelo, Maria Rosario; Felip, Enriqueta; Misch, Daniel; Kaur, Manmit; Bunn, Veronica; Lin, Huamao; Zhang, Pingkuan; Jänne, Pasi
Journal:
Lung cancer
Issue:
Volume 178(2023)Supplement 1
Page Start:
S35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis. Issue 5 (1st March 2022)

Authors:
Attygalle, Ayoma D; Dobson, Rachel; Chak, Pui Kwan; Vroobel, Katherine M; Wren, Dorte; Mugalaasi, Hood; Morgan, Yvonne; Kaur, Manmit; Ahmad, Raida; Chen, Zi; Naresh, Kikkeri N; Du, Ming‐Qing
Journal:
Histopathology
Issue:
Volume 80:Issue 5(2022)
Page Start:
847
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗